{"id":385948,"date":"2022-06-29T00:00:00","date_gmt":"2022-06-29T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47037328-medtech-structural-heart-closure-devices-market-insights-asia-pacific-2023\/"},"modified":"2026-03-31T10:13:56","modified_gmt":"2026-03-31T10:13:56","slug":"47037328-medtech-structural-heart-closure-devices-market-insights-asia-pacific-2023","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47037328-medtech-structural-heart-closure-devices-market-insights-asia-pacific-2023\/","title":{"rendered":"Structural Heart Closure Devices | Market Insights | Asia Pacific | 2023"},"content":{"rendered":"<p>The global\u00a0COVID-19\u00a0pandemic negatively impacted the Asia Pacific structural heart closure device market to some extent. Given most structural heart closure procedures, including congenital heart defect closure,\u00a0PFO\u00a0closure, and\u00a0LAA\u00a0closure, are considered nonurgent,\u00a0COVID-19\u00a0response measures resulted in strong declines in structural heart closure procedure volumes in early 2020, although strong prepandemic growth trends in the\u00a0PFO\u00a0and\u00a0LAA\u00a0segments helped to sustain\u00a0positive overall\u00a0procedure volume and market growth for the year. In 2021, procedure volume and market growth\u00a0increased strongly\u00a0as deferred procedures were performed, and going forward the market will\u00a0continue to expand\u00a0through 2031, fueled by\u00a0strong expansion\u00a0of the\u00a0PFO\u00a0and\u00a0LAA\u00a0closure device spaces.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the structural heart closure device market in Asia Pacific from 2019 through 2031.<\/p>\n","protected":false},"template":"","class_list":["post-385948","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-structural-heart-closure-devices","medtech-geography-asia-pacific","medtech-date-967"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385948","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385948\/revisions"}],"predecessor-version":[{"id":387457,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385948\/revisions\/387457"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385948"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}